News About: Pharm. Industry
Drugmakers struggling to clean up images
Influenced by the recent asbestos-containing talc problems, Korean pharmaceutical companies have been busy dealing with the situation.
Some companies are looking into all excipients contained in medicines, includin...
Lilly, Boehringer Ingelheim to co-market duloxetine
Lilly Korea and Boehringer Ingelheim Korea agreed to co-promote Cymbalta (duloxetine hydrochloride) from May.
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI), approved in more than 70 countries i...
Yoo named brand manager in Novartis headquarters
Yoo Soo Yeon, marketing manager of Novartis Korea’s Bone Metabolism & Respiratory (BMR) Unit, has been appointed as brand manager in Novartis Inc. in Switzerland.
Yoo will stay at the headquarters for 16 months fo...
Drugmakers’ stock prices up over swine flu fear
Pharmaceutical firms and related suppliers are seeing a rise in their stock prices as the World Health Organization has recently raised the alert level to Phase 4, meaning there is sustained human-to-human transmissio...
UCB Korea, Samil to strengthen co-marketing over Xyzal
UCB Korea and Samil Pharm will beef up their co-marketing efforts of XYZAL (levocetirizine), a third-generation non-sedative antihistamine.
Many people suffer from the symptoms associated with common allergic condi...
GSK’s new beta-blocker to be released in domestic hypertensive drug market
A new beta-blocker, Nebilet (nebivolol), will join the arsenal of drugs available to treat hypertension, according to GlaxoSmithKline (GSK)
Holding the launching symposium, GSK has signed an agreement with Italy ba...
Dual in home insecticides market
The domestic household insecticides market has reemerged as an arena of cutthroat competition among foreign and domestic pharmaceutical firms, business sources say.
Three local pharmaceutical companies – Yuhan Cor...
Hospital bidding prices should be readjusted, KPMA says
The Korea Pharmaceutical Manufacturers Association said the controversial hospital bidding drug prices should be controlled under the actually traded pricing system to prevent dual pricing of a same drug in hospital t...
Pfizer Korea recalls defected products of Lyrica
Pfizer Korea said it is initiating a recall of Lyrica (pregabalin) finished product lot No. 0505058 (expiry date: May 18, 2011) due to some of bloated capsules in the bottles (150mg x 60 capsules) that were found in e...
Handok, AEterna Zentaris sign licensing agreement over oral anti-cancer agent
Handok Pharm announced on April 23 announced the signing of a licensing agreement with Canada based AEterna Zentaris Inc. to distribute Perifosine in Korea, a novel, potentially first-in-class, oral anti-cancer agent ...
